Skip to main content


Nadja Haiden
Assoc.Prof. Nadja Haiden, MD.MSc.Head of Neonatal Nutrition Team (NNT)

Department of Pediatrics and Adolescent Medicine (Division of Neonatalogy, Intensive Care Medicine and Neuropediatrics)
Position: Associate Professor

T +43 1 40400 32320


Anemia; Blood Coagulation; Enteral Nutrition; Milk, Human; Neonatology; Nutrition Therapy; Parenteral Nutrition

Research group(s)

Research interests

My main research focus is to understand the mechanism of adequate growth in extreme and low birth weight infants and to prevent disease in this context (necrotizing enterocolitis). Preterm infants with a birth weight less than 1500 grams have special nutritional needs in comparison to full-term neonates. During their stay in the neonatal intensive care unit an increased supply with energy, protein, vitamins and electrolytes is necessary to establish adequate growth. After discharge from the hospital special breast milk supplements or post discharge formulas are available to cover the special nutrient requirements. Scientific research in this field focuses on growth, adaequate supplementation with nutrients and long term outcome. The group works in good cooperation with the department of clinical pharmacology in context of drug- or pharmacological research.  A second research focus is on anaemia of prematurity and coagulation disorders in preterm infants 

Techniques, methods & infrastructure

Clinical research, prospective randomized controlled trials, osmolarity measurements of human milk, measurements with the MIRIS breastmilk analyzer, body composition measurements of preterm and term infants with the PEAPOD, coagulation measurements with COAGUCHEK, 


  • Das PIES Projekt: frühe Beikosteinführung bei Frühgeborenen (2013)
    Source of Funding: OeNB (Oesterreichische Nationalbank), Anniversary Fund
    Principal Investigator

Selected publications

  1. Comparison of bacterial counts in expressed breast milk following standard or strict infection control regimens in neonatal intensive care units: compliance of mothers does matter. Haiden N, Pimpel B, Assadian O, Binder C, Kreissl A, Repa A, Thanhäuser M, Roberts CD, Berger A. J Hosp Infect. 2016 Mar;92(3):226-8. doi: 10.1016/j.jhin.2015.11.018. Epub 2016 Jan 6
  2. Does visceral osteopathic treatment accelerate meconium passage in very low birth weight infants?- A prospective randomized controlled trial. Haiden N, Pimpel B, Kreissl A, Jilma B, Berger A. PLoS One. 2015 Apr 15;10(4):e0123530. doi: 10.1371/journal.pone.0123530. eCollection 2015.
  3. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity. Haiden N, Klebermass K, Cardona F, Schwindt J, Berger A, Kohlhauser-Vollmuth C, Jilma B, Pollak A. Pediatrics. 2006 Jul;118(1):180-8
  4. Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants. Haiden N, Schwindt J, Cardona F, Berger A, Klebermass K, Wald M, Kohlhauser-Vollmuth C, Jilma B, Pollak A. Pediatrics. 2006 Nov;118(5):2004-13.
  5. The effect of an osmotic contrast agent on complete meconium evacuation in preterm infants. Haiden N, Norooz F, Klebermass-Schrehof K, Horak AS, Jilma B, Berger A, Repa A. Pediatrics. 2012 Dec;130(6):e1600-6. doi: 10.1542/peds.2011-3634. Epub 2012 Nov 26.